Contact Our Team
Our Story
Creative Proteomics established Olink Proteomics Services platform to deliver targeted, high-precision protein analysis to the global research community.
As a trusted multi-omics partner, we bring together years of expertise in proteomics, metabolomics, lipidomics and glycomics to support projects ranging from early discovery to preclinical studies.
By combining scientific rigour with a customer-first mindset, we aim to make high-throughput protein profiling accessible, reliable, and impactful.
What We Do for You
Your Protein Research. Advanced, Simplified, Accelerated.
We partner with scientists and research leaders to solve the toughest challenges in protein analysis:
Unlock deeper insights
Quantify thousands of proteins with just microlitres of sample.
Accelerate biomarker discovery
Identify, validate, and prioritise targets more efficiently.
Support every research stage
From exploratory studies to translational programs.
Why Choose Our Olink Proteomics Services?
PEA Technology Edge
Olink's Proximity Extension Assay delivers ultra-sensitive, specific, and scalable protein quantification.
Holistic Multi-omics Expertise
Beyond proteomics, we bring metabolomics and lipidomics to offer integrated biological insights.
Trusted by Global Innovators
Partnering with leading pharma companies, CROs, and academic labs for research-use-only studies.
Quality & Integrity
Rigorous QC ensures data reliability and reproducibility for every project.
Our Technology Leadership
PEA: A New Era in Protein Analysis
At the heart of our services is Olink's Proximity Extension Assay (PEA) — an innovative platform that merges immunoassay accuracy with DNA amplification power.
PWhat makes it different?
- Ultra-sensitive detection: fg/ml – mg/ml dynamic range
- Minimal input: as little as 1–8 μl
- High-throughput profiling: 100s to 5,000+ proteins in one run
- Flexible readouts: qPCR & NGS for maximum scalability
PEA technology allows scientists to see what was previously undetectable, creating new opportunities in biomarker discovery and translational science.
Great Minds Choose Creative Proteomics
Trusted by Leading Innovators Worldwide
Creative Proteomics partners with top pharmaceutical companies, research institutes, and CRO/CDMOs to advance multi-omics research and innovation.
Featured Publications
Empowering Research That Shapes the Future
Our clients have published their findings—supported by Creative Proteomics' multi omics expertise—in top journals such as PNAS, Stroke, and GeroScience.
These studies showcase how Creative Proteomics' expertise helps researchers turn raw data into meaningful breakthroughs.
Multiomics of a rice population identifies genes and pathways for grain quality and yield (2024)
— Comprehensive multi-omics profiling to improve rice protein yield and nutritional traits.
UDP Glucose/P2Y14 Receptor Signaling Exacerbates Brain Injury after Stroke (2024)
— Translational study elucidating novel signaling pathways in post stroke neurovascular damage.
White matter lipid alterations during aging in mouse brain (2024)
— Lipidomics-based insights into age-related changes in brain white matter integrity.
Our Laboratory
State-of-the-Art Research Infrastructure
Our U.S.-based laboratories feature cutting-edge proteomics, metabolomics, and lipidomics platforms.
With advanced instrumentation and strict QC processes, we deliver precise, reproducible, and research-use-only results that clients can trust.